) is known to accelerate reendothelialization and thus prevent intimal thickening and in-stent restenosis after angioplasty. Transplantation experiments with ER␣ Ϫ/Ϫ mice have previously shown that E 2 acts through local and bone marrow cell compartments to enhance endothelial healing. However, the downstream mechanisms induced by E 2 to mediate endothelial repair are still poorly understood. Methods and Results-We show here that after endovascular carotid artery injury, E 2 -enhanced endothelial repair is lost in osteopontin-deficient mice (OPN Ϫ/Ϫ ). Transplantation of OPN Ϫ/Ϫ bone marrow into wild-type lethally irradiated mice, and vice versa, suggested that osteopontin plays a crucial role in both the local and the bone marrow actions of E 2 . In the vascular compartment, using transgenic mice expressing doxycyclin regulatable-osteopontin, we show that endothelial cell specific osteopontin overexpression mimics E 2 -enhanced endothelial cell migration and proliferation in the regenerating endothelium. In the bone marrow cell compartment, we demonstrate that E 2 enhances bone marrow-derived mononuclear cell adhesion to regenerating endothelium in vivo, and that this effect is dependent on osteopontin. Conclusions-We demonstrate here that E 2 acceleration of the endothelial repair requires osteopontin, both for bone marrow-derived cell recruitment and for endothelial cell migration and proliferation. (Arterioscler Thromb Vasc Biol. 2008;28:2131-2136.)
M aintaining the integrity and function of the endothelial barrier is critical to vessel physiology. Indeed, endothelial damages lead to activation of thrombosis processes, namely after percutaneous transluminal coronary angioplasty often associated with stent fixing. It is now accepted that improving the reendothelialization process limits stentinduced thrombi formation.
See accompanying article on page 2099
Endothelial repair clearly involves migration and proliferation of endothelial cells (EC), which are in interaction with extracellular matrix proteins, 1,2 as well as recruitment of bone marrow (BM)-derived cells including endothelial progenitor cells (EPC). 3 At the molecular level, growth factors such as VEGF, 4 FGF2, 5 and compounds such as statins, 3 prostacyclins, 6 and estrogens 7 accelerate endothelial repair. As previously demonstrated by us and others, 17␤-estradiol (E 2 ) accelerates endothelial healing via the estrogen receptor ER-␣ but not ER-␤ 8 and through the involvement of endothelial NO synthase (eNOS) 9,10 and basic FGF. 11 This effect of E 2 is mediated by BM cells, because it is lost in wild-type mice grafted with ER␣-deficient BM cells. 11 Moreover, E 2 allows mobilization of EPCs 12 and increases their number in the regenerating area of wounded arteries. 9 On the other hand, E 2 favors the proliferation and migration of ECs 13 and prevents them from undergoing apoptosis. 14 Despite these various effects, the molecular and cellular mechanisms that might account for the stimulating effects of E 2 on endothelial repair remain unclear. 7, 15 Since the 1990s, estrogens have been known to regulate the synthesis of osteopontin (OPN). 16 A first in vivo report demonstrated that in absence of OPN, mice are resistant to ovariectomy-induced bone resorption. 17 Inhibition of OPN expression by estrogens was also found in vascular smooth muscle cells (SMCs) in vitro and in vivo. 18 Conversely, estrogens are known to induce OPN expression in osteoblasts, 19 in the kidney, 20 and in the uterus luminal epithelium. 21 Estrogen responsive elements were actually identified in the OPN promoter. 22, 23 Estrogen regulation of OPN promoter in ECs or EPCs is not known. OPN functions both as a cell attachment protein and as a chemokine, delivering signals to the cells via a number of receptors including several integrins and CD44. 24 Moreover an intracellular form of OPN is also involved in cell adhesion and migration. 25 As a cell attachment protein, OPN allows adhesion of numerous cell types including ECs. 26 As a signaling molecule, OPN is able to modify gene expression and promote migration of various cell types including ECs, osteoclasts, monocytes, 26 and SMCs. 27 Moreover, OPN inhibits apoptosis in ECs 28 and is involved in angiogenesis 29 and postischemic neovascularization. 30, 31 In contrast to uninjured blood vessels where very little OPN is expressed, abundant levels of OPN were found in the remodeling media after balloon injury and in atherosclerosic plaques. OPN was also found at the regenerating endothelium wound edge 26 and VEGF, which mediates acceleration of the reendothelialization, increased OPN expression in ECs, 32 suggesting an involvement of OPN in endothelial repair. However, a recent report showed that in vitro, OPN overexpression dramatically impaired reendothelialization by inhibiting EC motility. 33 Thus the role of OPN in vivo must be clarified.
Here, we have investigated the mechanisms involved in E 2 -stimulated endothelial repair and evaluated the implication of OPN in this process. We demonstrate that OPN is required for E 2 to accelerate endothelial repair through cooperation between two cell compartments, ECs and BM-derived cells.
Materials and Methods

Mice
Mice were maintained in a conventional animal facility, on a 12-hour light/12-hour dark cycle. Food and water were available ad libitum. All procedures were carried out in compliance with the principles and guidelines established by the National Institute of Medical Research (INSERM) and approved by the Institutional Animal Care and Use Committee. Animals were anesthetized by an intraperitoneal injection of ketamine (100 mg/kg) and xylazine (10 mg/kg).
OPN deficient mice (OPN Ϫ/Ϫ ) are global knockout. Genotyping was performed as previously described. 34 Tie2-rOPN mice (Tet off) were obtained by mating Tie2-tTA mice 35, 36 with TRE-rOPN mice carrying mouse recombinant OPN (rOPN) under the control of the doxycyclin/tetracycline regulatory element (TRE; please see supplemental materials, available online at http://atvb.ahajournals.org). This construct should allow coexpression of OPN and ␤-galactosidase with some differences (supplemental Figures I and II). Doxycyclin (7.8 mmol/L, Sigma) was added to the drinking water for 7 days before the experiment.
Animals were ovariectomized at 5 weeks of age and s.c. implanted in the back with either placebo or E 2 releasing pellets (0.1 mg E 2 delivering 80 g/kg/d, Innovative Research of America). Carotid injury was generally performed 2 to 3 weeks after pellet implantation.
Bone Marrow Transplantation
Two weeks after ovariectomy, recipient mice were lethally ␥-irradiated (9 Gy). Twenty-four hours later, they received an intravenous injection of 4ϫ10 6 donor BM cells. One month later, mice were implanted with either placebo or E 2 pellet.
Mouse Carotid Injury and Quantification of Endothelial Regeneration
Endovascular injury of the right carotid was performed mechanically using an in-house made swab (please see supplemental materials). No intimal thickening was observed after this endovascular injury.
Endothelial repair was evaluated by staining the denuded areas with Evans blue dye (Merck; please see supplemental materials) Percentage between blue stained area (unrepaired area) and injured carotid artery area was calculated.
Proliferating EC was evaluated by immunodetection of incorporated 5-bromo-2-deoxyuridine (please see supplemental materials). Proliferation index was calculated by dividing the number of proliferating ECs in ARA or RA by the respective surfaces of these areas.
Immunohistochemistry
OPN protein was detected using a goat polyclonal anti-OPN antibody (Sigma). ECs were identified using anti-CD31 antibody (BD Pharmigen), and nuclei were stained by the DAPI. The control antibody is a goat non immune IgG (Sigma).
In Vivo BM MNC Adhesion Test
The BM was flushed out of the cleaned bone (femur and tibia) with PBS. Mononuclear cells (MNCs) were isolated on a Ficoll gradient (Ficoll-Paque Plus, GE Healthcare, 1100 rpm, 30 minutes) and resuspended in EGM2 Bulletkit medium (Clonetics).
Two hours after carotid injury, mice received a retro-orbital injection of 4ϫ10 6 PKH26-GL (Sigma) labeled BM MNC suspended in 250 L of 150 mmol/L NaCl (please see supplemental materials). The recipient mouse carotids were harvested 24 hours later. The fluorescent BM MNCs adhering to the wounded area of the carotid artery were counted using fluorescent microscopy.
Statistical Analysis
Results are expressed as meansϮSEM. Data were analyzed using Kruskal-Wallis 1-way ANOVA with NCSS statistical software. When the test indicated that at least 2 medians are different (probability value Ͻ0.05), a 2-sample t test (Mann-Whitney U) was performed to compare medians of each group to each other. A probability value Ͻ0.05 indicated significant difference between 2 groups. It was indicated by *. Nonsignificant difference was indicated by NS.
Results
Endothelial OPN Contributes to Endothelial Repair
Previous conflicting in vitro reports show either that OPN is chemotactic for ECs 26 or in contrast that it inhibits in vitro reendothelialization in a model of cultured EC layer injury. 33 To clarify this point, we have generated Tie2-rOPN transgenic mice designed to overexpress recombinant OPN in ECs in a doxycyclin-regulatable fashion (Tet-Off strategy). These mice allowed to evaluate the role of EC OPN expression during in vivo EC migration occurring during the endothelial repair after experimental endothelial injury of the mouse carotid artery.
In Tie2-rOPN mice, immunohistological analyses showed that OPN protein is expressed in all the ECs of the healthy carotid artery while it is not detected in healthy carotid artery of wild-type mice (supplemental Figure II) . In these mice, the endothelial repair was accelerated compared to that in Tie2-rOPN mice in which the transgene expression was inhibited by doxycyclin (ϩDox) ( Figure 1 ). These data demonstrate that in vivo, OPN overexpression in ECs induced an acceleration of the endothelial repair and thus suggest that in vivo, OPN increases EC migration.
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As previously reported, 8 E 2 treatment of ovariectomized wild-type mice induced a significant increase of the repaired endothelial area measured 3 and 5 days after injury compared to placebo-treated mice (supplemental Figure IIIA ; Figure  2A ). Interestingly, the E 2 effect was lost in OPN-deficient (OPN Ϫ/Ϫ ) mice. Because the endothelial repair was identical in OPN ϩ/ϩ and OPN Ϫ/Ϫ placebo-treated mice (Figure 2A) , this experiment demonstrated that OPN is required for the E 2mediated acceleration of endothelial repair. When OPN expression was rescued in EC of OPN Ϫ/Ϫ mice expressing rOPN (Tie2-rOPN x OPN Ϫ/Ϫ mice in absence of doxycyclin), endothelial healing was accelerated compared to that in control doxycyclin-watered mice (Figure 1 ). Endothelial OPN overexpression, alone, was thus sufficient to induce an acceleration of the endothelial repair. This led us to postulate that OPN is a crucial downstream mediator of E 2 effects on endothelial healing.
To characterize events involved in E 2 -mediated endothelial repair, proliferating ECs were identified and counted. The number of proliferating ECs in the injured carotid 5 days after injury was significantly increased in E 2 -treated compared to placebo-treated OPN ϩ/ϩ mice ( Figure 2B ). Proliferating ECs were found not only in the repaired endothelium area (RA) but also in a retrograde area (ARA) located in the healthy endothelium upstream of the lesion site. Respective surfaces of these 2 areas were strongly increased in E 2 -treated OPN ϩ/ϩ mice ( Figure 2C ; supplemental Figure IIIB and IIIC). In the RA, the E 2 -mediated increase in proliferating ECs was proportional to the increase of its surface. The proliferating EC index was thus not significantly different with placebo or E 2 treatment ( Figure 2D ). In contrast, in the ARA, the proliferation index was significantly increased in E 2 -treated OPN ϩ/ϩ mice ( Figure 2D) .
In OPN Ϫ/Ϫ mice, E 2 was unable to increase the number of proliferating ECs, or to increase the ARA size, which were similar to those in OPN ϩ/ϩ mice with placebo treatment ( Figure 2B and 2C) .
These results thus demonstrate that the E 2 -mediated processes leading to the acceleration of endothelial repair absolutely require OPN.
Origin of OPN Required for the Effect of E 2 on Endothelial Healing
The OPN required for the E 2 -induced endothelial repair increase could come from either vascular or nonvascular cells. OPN was not detected in any layer of the healthy carotid artery of wild-type mice (supplemental Figure II) . In contrast, 3 days after endothelium removal, OPN protein was detected in SMCs of the media in the vicinity of the carotid artery bifurcation and in inflammatory cells present in the adventitia, mainly at the level of areas that remained deendothelialized (Figure 3, right panel) . Interestingly, OPN was also detected in ECs of the endothelial repaired area but not in ECs of the uninjured endothelial area far from the limit of injury (Figure 3 ).
Because we previously had shown BM-derived cells to be involved in the E 2 effect on reendothelialization, 11 we have studied OPN expression in cultured BM-derived cells and demonstrate here that these cells not only expressed the OPN protein (supplemental Figure IVA) but also that the level of OPN expression was dependent on E 2 activity (supplemental Figure IVB) .
We further tested the involvement of OPN from either BM-derived or vascular cells in E 2 effect. We therefore generated hematopoietic chimeric mice by grafting OPN Ϫ/Ϫ BM to lethally irradiated OPN ϩ/ϩ mice and vice versa. One month after grafting, endothelial repair was assessed 3 days after endothelial injury. In control mice (OPN ϩ/ϩ BMϾ Ͼ OPN ϩ/ϩ mouse), E 2 still induced an acceleration of endothelial repair, showing that neither the irradiation nor the BM transplantation altered the E 2 effect (Figure 4 ). When OPN ϩ/ϩ BM was grafted in OPN Ϫ/Ϫ mice, E 2 was unable to accelerate the endothelial repair, suggesting that OPN from BM-derived cells is not sufficient to mediate the E 2 effect. Similarly, when OPN Ϫ/Ϫ BM was grafted in OPN ϩ/ϩ mice, E 2 was also unable to induce an acceleration of the endothelial repair ( Figure 4) . These results suggest that OPN expression in both BMderived cells and the remaining vascular cells is required to bring about the E 2 effect on reendothelialization.
OPN Is Involved in the E 2 -Induced Increase of BM-Derived Cell Adhesion on the Regenerating Endothelial Area
Although OPN is required in E 2 -mediated reendothelialization, and E 2 supplementation increases EPC number, results of supplemental Figure V indicated that the loss of the E 2 effect on reendothelialization in OPN Ϫ/Ϫ mice was not the result of an alteration of the mobilization of this BM-derived cell population.
According to the adhesive property of OPN, 37 we hypothesized that the OPN contribution to reendothelialization could be mediated through its capacity to enhance the adhesion of BM-derived cells to the injured carotid artery in the presence of E 2 . We therefore investigated the ability of PKH26-GLlabeled BM MNCs from OPN ϩ/ϩ or OPN Ϫ/Ϫ mice to adhere to the injured carotid artery of OPN ϩ/ϩ or OPN Ϫ/Ϫ ovariectomized mice treated with E 2 or placebo. We showed first that OPN Ϫ/Ϫ BM MNCs adhered to a lesser extent than OPN ϩ/ϩ BM MNCs to OPN ϩ/ϩ mouse injured carotid artery ( Figure  5 ). Moreover a decrease in OPN ϩ/ϩ BM MNC adhesion to OPN Ϫ/Ϫ injured carotid artery was observed. Finally we tested the E 2 effect and demonstrated that BM MNC adhesion was enhanced by E 2 supplementation only when both MNCs and vascular cells expressed OPN ( Figure 5 ). Altogether these data demonstrate that OPN is involved in BM-derived cell adhesion in vivo and is required for increased adherence induced by E 2 treatment.
Discussion
We report here for the first time that E 2 requires the multifunctional protein OPN to mediate acceleration of endothelial repair after injury. Moreover, we show that this is a complex process requiring vascular as well as BM-derived events because OPN from both bone marrow and nonbone marrow origins is involved in this process.
Reendothelialization is mainly the result of migration and proliferation of ECs located at the edges of the lesion site in the rat aorta. 1 In the mouse carotid, the reendothelialization process occurs mainly from the proximal edge of the injured endothelium, in the direction of the blood flow. 2 Previous reports suggested that, in vitro, E 2 was able to increase EC migration and proliferation. 13 We demonstrate here that, in vivo, E 2 is able to increase the EC proliferation index not only in the regenerating area (RA) but also in a healthy endothelial area located upstream of the lesion (ARA), thus suggesting that the increased rate of endothelial repair resulted from an enhanced EC migration toward the acellular area. 2 In this article we demonstrate that E 2 -mediated enhancement of EC migration and proliferation is dependent on OPN. Indeed E 2 was unable to induce these effects in OPN Ϫ/Ϫ mice. Thus, OPN could be considered as a downstream component of the E 2 pathway in EC.
Since 1995, OPN was recognized as a chemotactic factor for ECs. 26 A controversy regarding the role of OPN originated from the work of Leali et al, 33 which showed that OPN overexpression inhibited in vitro reendothelialization. Our data suggest that OPN is not required for E 2 -independent in vivo reendothelialization, because the velocity of endothelial repair was identical in OPN ϩ/ϩ and OPN Ϫ/Ϫ mice under placebo treatment but is required for E 2 -mediated increase of endothelial repair. The fact that OPN deficiency did not affect endothelial repair suggested that an E 2 -independent compensatory mechanism could occur in OPN Ϫ/Ϫ mice. When OPN was constitutively expressed in an EC-specific manner in the TET-inducible transgenic mouse model, reendothelialization was accelerated, suggesting that in vivo, OPN overexpression indeed stimulates endothelial repair. This result underlines the difference between in vivo and in vitro studies probably linked to the differences in EC phenotype, in the extracellular matrix layer and potentially at the level of OPN expression in ECs.
Bone marrow transplantation experiments demonstrating that OPN, whether from the bone marrow or the local compartments, is unable to assume alone the E 2 -mediated improvement of the endothelial repair, suggested an autocrine role for OPN. Because the intracellular form of OPN has been previously involved in osteoblast and fibroblast migration, 25 we can also hypothesize that in our in vivo model, OPN would act intracellularly in ECs rather than through an extracellular action involving integrin engagement. 33 Neointima formation after acute endovascular injury is inhibited by E 2 supplementation and different mechanisms have been proposed including inhibition of SMC migration and proliferation, and stimulation of reendothelialization. 12, 38 Interestingly, it was suggested by an in vitro study that E 2 inhibits OPN expression in SMCs, which is required for adventitial fibroblast migration involved in intimal thickening. 18 In addition, our data show that E 2 mediates the acceleration of endothelial repair through an OPN-dependent pathway suggesting dual opposite roles for OPN in SMCs and ECs, which both contribute to neointima inhibition.
Different lines of evidence show that E 2 increased the number of EPCs in BM and blood but also in the regenerating endothelium. 9, 12 We show here that E 2 not only increases BM mobilization but also enhances their homing to the injured area, and that OPN is required in this last effect. Mechanisms involved in the homing are complex, but adhesion molecules previously known to be involved in phases of rolling and firm adhesion of leukocytes appear as key regulators. Here we suggest that OPN is also a key factor of the BM cell homing.
How OPN is involved remains unclear, but this effect is probably linked to the OPN ability to bind on one side to integrin and CD44 receptors and on the other side to extracellular matrix components, notably to collagen.
Altogether, these results suggest a possible cascade of events occurring during E 2 -mediated acceleration of endothelial repair ( Figure 6 ). In a first step, E 2 increases the pool of BM-derived cells according to a mechanism involving FGF2 11 but not OPN. Then, E 2 induces the production of OPN by BM-derived cells, allowing them to more efficiently adhere to endothelial regenerating areas. The role of adherent BM-derived cells is still unknown, but they could contribute to an OPN-dependent E 2 -mediated stimulation of EC migration from the adjacent healthy zone. Finally, we can speculate that consequently to the EC migration from the healthy adjacent endothelium (ARA) toward the deendothelialized area, the cell density decreases in ARA, leading to an EC proliferation to refill an adequate cell density. 
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